Cas no 332366-57-1 (6-Bromoquinolin-4(1H)-one)
6-Bromoquinolin-4(1H)-one Chemical and Physical Properties
Names and Identifiers
-
- 6-Bromoquinolin-4(1H)-one
- 6-Bromo-1,4-dihydroquinolin-4-one
- 6-Bromo-1H-Quinilin-4-One
- 6-Bromo-4(1H)-quinolinone
- 6-bromoquinolin-4-ol
- 6-Brom-3-<2-pyridyl>-cumarin
- 6-bromo-1H-quinolin-4-one
- 6-bromo-4-oxo-4H-quinoline
- 6-bromoquinolone
- 6-Bromo-4-quinolone
-
- MDL: MFCD07644510
- Inchi: 1S/C9H6BrNO/c10-6-1-2-8-7(5-6)9(12)3-4-11-8/h1-5H,(H,11,12)
- InChI Key: XKLBNOHKHRAXKK-UHFFFAOYSA-N
- SMILES: BrC1C=CC2=C(C=1)C(C=CN2)=O
Computed Properties
- Exact Mass: 222.96300
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 12
- Rotatable Bond Count: 0
Experimental Properties
- Density: 1.620±0.06 g/cm3 (20 oC 760 Torr),
- Melting Point: 286 oC
- Boiling Point: 321.7±42.0°C at 760 mmHg
- Solubility: Very slightly soluble (0.36 g/l) (25 o C),
- PSA: 32.86000
- LogP: 2.29060
6-Bromoquinolin-4(1H)-one Security Information
- Hazard Statement: H302-H315-H319-H335
- Storage Condition:Sealed in dry,2-8°C
6-Bromoquinolin-4(1H)-one Customs Data
- HS CODE:2933499090
- Customs Data:
China Customs Code:
2933499090Overview:
2933499090. Other compounds containing quinoline or isoquinoline ring system [but not further fused]. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
6-Bromoquinolin-4(1H)-one Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A189005795-10g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 95% | 10g |
$198.00 | 2023-09-02 | |
| Alichem | A189005795-25g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 95% | 25g |
$493.92 | 2023-09-02 | |
| TRC | B807888-100mg |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 100mg |
$ 64.00 | 2023-04-18 | ||
| TRC | B807888-250mg |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 250mg |
$ 75.00 | 2023-04-18 | ||
| TRC | B807888-1g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 1g |
$ 65.00 | 2022-06-06 | ||
| TRC | B807888-5g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 5g |
$ 253.00 | 2023-04-18 | ||
| SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd. | B893608-5g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 97% | 5g |
520.20 | 2021-05-17 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DN739-5g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 97% | 5g |
743.0CNY | 2021-07-12 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DN739-250mg |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 97% | 250mg |
137CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-DN739-1g |
6-Bromoquinolin-4(1H)-one |
332366-57-1 | 97% | 1g |
208.0CNY | 2021-07-12 |
6-Bromoquinolin-4(1H)-one Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
-
J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
Additional information on 6-Bromoquinolin-4(1H)-one
Comprehensive Analysis of 6-Bromoquinolin-4(1H)-one (CAS No. 332366-57-1): Properties, Applications, and Research Insights
6-Bromoquinolin-4(1H)-one (CAS No. 332366-57-1) is a brominated quinoline derivative that has garnered significant attention in pharmaceutical and materials science research. This heterocyclic compound, characterized by its bromine substitution at the 6-position and a ketone functional group at the 4-position, serves as a versatile intermediate in organic synthesis. Its molecular formula, C9H6BrNO, and unique structural features make it invaluable for designing drug candidates and functional materials.
Recent studies highlight the growing demand for 6-Bromoquinolin-4(1H)-one in medicinal chemistry, particularly in the development of kinase inhibitors and antimicrobial agents. Researchers are exploring its potential in targeting cancer pathways and antibiotic-resistant bacteria, aligning with global health priorities. The compound's electron-rich quinoline core facilitates interactions with biological targets, while the bromine atom enhances reactivity for further derivatization.
From a synthetic perspective, CAS No. 332366-57-1 is often synthesized via halogenation reactions of quinolin-4(1H)-one precursors. Optimized protocols emphasize green chemistry principles, such as solvent-free conditions or catalytic methods, to reduce environmental impact—a topic increasingly relevant to sustainable pharmaceutical manufacturing. Analytical techniques like HPLC, NMR, and mass spectrometry ensure high purity (>98%), critical for reproducibility in preclinical studies.
The compound's physicochemical properties—including solubility in polar aprotic solvents and thermal stability up to 200°C—make it suitable for diverse applications. In material science, it acts as a building block for organic semiconductors and luminescent materials, addressing trends in flexible electronics and OLED technology. Its fluorescence properties are also investigated for bioimaging probes.
Frequently searched questions about 6-Bromoquinolin-4(1H)-one include: "What are the synthetic routes for CAS 332366-57-1?", "How does bromination affect quinoline reactivity?", and "Can this compound be used in COVID-19 drug repurposing?". While direct antiviral data remains limited, its scaffold similarity to known protease inhibitors sparks interdisciplinary interest.
Regulatory compliance for 6-Bromoquinolin-4(1H)-one focuses on standard laboratory safety protocols (e.g., PPE, ventilation). Unlike restricted quinoline analogs, its non-controlled status facilitates academic and industrial research. Storage recommendations (-20°C, inert atmosphere) preserve stability, while supply chain transparency ensures traceability—a key concern for quality-focused buyers.
Future directions may explore computational modeling to predict new derivatives or nanocarrier formulations for enhanced bioavailability. As precision medicine advances, the role of CAS 332366-57-1 in targeted therapy design could expand, particularly in orphan disease research where quinoline motifs show promise.
332366-57-1 (6-Bromoquinolin-4(1H)-one) Related Products
- 123420-09-7(2-Amino-6-bromo-4-quinolinol)
- 956268-33-0(7-Bromoquinolin-4(1H)-one)
- 145369-94-4(6-Bromoquinolin-4-ol)
- 57798-00-2(8-Bromoquinolin-4(1H)-one)
- 103030-28-0(6-Bromo-2-methylquinolin-4-ol)
- 23432-40-8(6-Methylquinolin-4-ol)
- 97545-52-3(6-methyl-1,4-dihydroquinolin-4-one)
- 949507-29-3(8-Bromo-1,4-dihydroquinolin-4-one)
- 723283-89-4(5-Bromoquinolin-4-ol)
- 303121-13-3(6-ethylquinolin-4-ol)